GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Days Payable

ZBIO (Zenas BioPharma) Days Payable : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zenas BioPharma Days Payable?

Zenas BioPharma's average Accounts Payable for the three months ended in Sep. 2024 was $11.72 Mil. Zenas BioPharma's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.00 Mil.

The historical rank and industry rank for Zenas BioPharma's Days Payable or its related term are showing as below:

ZBIO's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

Zenas BioPharma's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Zenas BioPharma Days Payable Historical Data

The historical data trend for Zenas BioPharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenas BioPharma Days Payable Chart

Zenas BioPharma Annual Data
Trend Dec22 Dec23
Days Payable
- -

Zenas BioPharma Quarterly Data
Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Payable Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Zenas BioPharma's Days Payable

For the Biotechnology subindustry, Zenas BioPharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenas BioPharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenas BioPharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Zenas BioPharma's Days Payable falls into.


Zenas BioPharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zenas BioPharma's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (5.815 + 5.396) / 2 ) / 0*365
=5.6055 / 0*365
=N/A

Zenas BioPharma's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

Days Payable (Q: Sep. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2024 ) + Accounts Payable (Q: Sep. 2024 )) / count ) / Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=( (8.358 + 15.082) / 2 ) / 0*365 / 4
=11.72 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenas BioPharma Days Payable Related Terms

Thank you for viewing the detailed overview of Zenas BioPharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenas BioPharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Days Payable
Comparable Companies
Traded in Other Exchanges
N/A
Address
1000 Winter Street, North Building, Suite 1200, Waltham, MA, USA, 02451
Website
https://www.zenasbio.com
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.